Evaluation of the 1-Year Efficacy and Tolerability of Inclisiran in Coronary Artery Disease Patients
{{output}}
Background: Clinical trial results suggest inclisiran lowers low-density lipoprotein-cholesterol (LDL-C), but long-term real-world data in Japanese coronary artery disease (CAD) patients are limited. ... ...
